309 related articles for article (PubMed ID: 11602227)
1. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW; Noraberg J; Zimmer J
Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
[TBL] [Abstract][Full Text] [Related]
2. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
3. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
[TBL] [Abstract][Full Text] [Related]
4. Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures.
May PC; Robison PM
J Neurochem; 1993 Mar; 60(3):1171-4. PubMed ID: 7679725
[TBL] [Abstract][Full Text] [Related]
5. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
Moncada C; Arvin B; Le Peillet E; Meldrum BS
Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
[TBL] [Abstract][Full Text] [Related]
6. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors.
Chen Q; Harris C; Brown CS; Howe A; Surmeier DJ; Reiner A
Exp Neurol; 1995 Dec; 136(2):212-24. PubMed ID: 7498411
[TBL] [Abstract][Full Text] [Related]
7. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
8. Development of kainic acid and N-methyl-D-aspartic acid toxicity in organotypic hippocampal cultures.
Bruce AJ; Sakhi S; Schreiber SS; Baudry M
Exp Neurol; 1995 Apr; 132(2):209-19. PubMed ID: 7540554
[TBL] [Abstract][Full Text] [Related]
9. Evidence that GYKI 52466, a novel non-NMDA antagonist enhances the decay of kainate-induced current in cultured chicken cortical neurons.
Osipenko O; Mike A; Gyevai A; Vizi ES
Brain Res Dev Brain Res; 1994 Feb; 77(2):257-63. PubMed ID: 7513623
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures.
Vornov JJ; Tasker RC; Park J
Exp Neurol; 1995 May; 133(1):7-17. PubMed ID: 7541369
[TBL] [Abstract][Full Text] [Related]
11. L-glutamate-induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells.
Winter CR; Baker RC
Life Sci; 1995; 57(21):1925-34. PubMed ID: 7475942
[TBL] [Abstract][Full Text] [Related]
12. NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum.
Wang T; French ED
Brain Res Bull; 1995; 36(1):39-43. PubMed ID: 7533638
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
Zeman S; Lodge D
Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
[TBL] [Abstract][Full Text] [Related]
14. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR
J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo.
Obrenovitch TP; Urenjak J; Zilkha E
Br J Pharmacol; 1994 Dec; 113(4):1295-302. PubMed ID: 7534184
[TBL] [Abstract][Full Text] [Related]
16. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
Prehn JH; Lippert K; Krieglstein J
Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
[TBL] [Abstract][Full Text] [Related]
17. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity.
Dugan LL; Bruno VM; Amagasu SM; Giffard RG
J Neurosci; 1995 Jun; 15(6):4545-55. PubMed ID: 7540679
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
[TBL] [Abstract][Full Text] [Related]
19. Electrogenic uptake contributes a major component of the depolarizing action of L-glutamate in rat hippocampal slices.
Frenguelli BG; Blake JF; Brown MW; Collingridge GL
Br J Pharmacol; 1991 Feb; 102(2):355-62. PubMed ID: 1673070
[TBL] [Abstract][Full Text] [Related]
20. Felbamate selectively blocks in vitro hippocampal kainate-induced irreversible electrical changes.
Longo R; Domenici MR; Scotti de Carolis A; Sagratella S
Life Sci; 1995; 56(21):PL409-14. PubMed ID: 7537844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
